e-Drug3D

206

DESERPIDINE

DISCONTINUED


INN
DESERPIDINE

cas 131-01-1
CLASS

CARDIOVASCULAR
ANTIHYPERTENSIVE
IS A COMPETITIVE INHIBITOR OF THE ANGIOTENSIN CONVERTING ENZYME (ACE) (PUBCHEM CID8550)

ROUTE (list)

ORAL

NATURAL MOLECULE (link)

ATC code

C02AA05
C02LA03

PK parameters

Target

TARGET ANGIOTENSIN-CONVERTING ENZYME

DrugCentral

Synaptic vesicular amine transporter UNIPROT Q05940 SLC18A2

Download SDF file Yohimban-16-carboxylic acid, 17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)-

Formula:
C32H38N2O8

Calculated chemical properties:

MW 578.64
NB_atoms 42
XLogP 4.16
PSA 91.475
NB_HD 1
NB_HA 10
fsp3 0.50
Lipinski(0=no;1=yes) 0

FDA
NDA 088452 (pdf not found) INN (DESERPIDINE ; METHYCLOTHIAZIDE) METHYCLOTHIAZIDE AND DESERPIDINE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 088486 (pdf not found) INN (DESERPIDINE ; METHYCLOTHIAZIDE) METHYCLOTHIAZIDE AND DESERPIDINE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 010796 (pdf not found) INN (DESERPIDINE) HARMONYL (ABBVIE) APPROVAL= AP YEAR= 1957 NEWMOLECULARENTITY DISCONTINUED
NDA 012148 (pdf not found) INN (DESERPIDINE ; HYDROCHLOROTHIAZIDE) ORETICYL 25 (ABBVIE) APPROVAL= AP YEAR= 1959 DISCONTINUED
NDA 012775 (pdf not found) INN (DESERPIDINE ; METHYCLOTHIAZIDE) ENDURONYL (ABBOTT) APPROVAL= AP YEAR= 1961 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL